Plain-English translation of NCT07085611 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study that tracks how your body's immune system responds to COVID-19 and monkeypox vaccines or antibody treatments over several years. Researchers will collect blood and nasal samples at different timepoints to measure the strength and durability of your immune response. This helps scientists understand how long vaccine protection lasts and how effective the treatment is.
Scientists need to understand how long immunity lasts after vaccination or antibody treatment, and whether protection weakens over time. This information helps doctors decide whether booster shots are needed and helps improve future vaccines.
You likely qualify if…
You likely don't qualify if…
You will visit the study site to have blood and nasal samples collected — similar to getting a blood test and a gentle nasal swab. These sample collections happen multiple times over up to 5 years to track how your immune response changes. The study doesn't give you any medication; it simply measures your body's response to vaccines or treatments you're already receiving as part of your normal care.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
France
Centre Hospitalier Régional d'Orléans
Enrollment target
~30 participants
Started
August 2025
Primary completion
August 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thierry PRAZUCK, Dr
CHU Orléans
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.